UK_FTS process · buyer country GB · contract
BCU-FTS-59576 Cellular Pathology Reagent Delivery and Collection
Betsi Cadwaladr University Health Board
- Buyer identifier
- GB-PPON: PHBY-3981-QBMR
- Primary supplier
- CellPath Limited
- Procurement method
- Open procedure
- Tender deadline
- Not reported
- Contract period
- Oct 1, 2026 — Sep 30, 2029
- Native value
- GBP 175,000
- USD comparison
- Not shown — no auditable FX observation
- Official source
- Open notice ↗
Description
Betsi Cadwaladr University Health Board (BCUHB) Cellular Pathology routinely uses substantial volumes of Formalin, Xylene, and other specialised reagents in the histological preparation and analysis of tissue specimens. These reagents are critical in investigating a broad spectrum of conditions, including malignant and benign tumours, as well as other tissue and cellular abnormalities, to enable accurate diagnosis and guide targeted treatment pathways. BCUHB seeks to appoint a suitably qualified supplier capable of delivering a reliable and timely supply of these reagents, alongside a dedicated service for the safe collection and compliant disposal of associated chemical waste. This will ensure uninterrupted laboratory operations, full regulatory compliance, and continuity of service.
Suppliers
- CellPath Limited · primary
Official lifecycle
Process timeline
- Award announced
BCU-FTS-59576 Cellular Pathology Reagent Delivery and Collection
- Contract signed
BCU-FTS-59576 Cellular Pathology Reagent Delivery and Collection
Auditable model output
Predictive intelligence
Append-only source history
Source records
| Record | Date | Stages | Fetched |
|---|---|---|---|
| 099518-2026 | Oct 21, 2026 | award, contract | Oct 22, 2026 |